Riva, M., Ravano, E., Cairoli, R., Molteni, A. (2017). DANAZOL TREATMENT FOR THROMBOCYTOPENIA IN LOWER-RISK MYELODYSPLASTIC SYNDROMES: A REAL LIFE EXPERIENCE. Intervento presentato a: 22nd Congress of the European-Hematology-Association - JUN 22-25, 2017, Madrid, SPAIN.

DANAZOL TREATMENT FOR THROMBOCYTOPENIA IN LOWER-RISK MYELODYSPLASTIC SYNDROMES: A REAL LIFE EXPERIENCE

Cairoli, R;
2017

paper
https://www.webofscience.com/wos/woscc/full-record/WOS:000404127004017?SID=EUW1ED0D866yuMSvLRbghY6NXMCHP#:~:text=Research Areas-,Hematology,-Major Concepts From
English
22nd Congress of the European-Hematology-Association - JUN 22-25, 2017
2017
2017
102
S2
490
491
E1195
none
Riva, M., Ravano, E., Cairoli, R., Molteni, A. (2017). DANAZOL TREATMENT FOR THROMBOCYTOPENIA IN LOWER-RISK MYELODYSPLASTIC SYNDROMES: A REAL LIFE EXPERIENCE. Intervento presentato a: 22nd Congress of the European-Hematology-Association - JUN 22-25, 2017, Madrid, SPAIN.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/409595
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact